Methods of activating a melanocortin-4 receptor pathway in obese subjects
AssigneesEthicon Endo-Surgery, Inc., The General Hospital Corporation
InventorsLee M. Kaplan, Nicholas Stylopoulos, Jason L. Harris
Life of this patent
Estimating the term…
Loading patent…
AssigneesEthicon Endo-Surgery, Inc., The General Hospital Corporation
InventorsLee M. Kaplan, Nicholas Stylopoulos, Jason L. Harris
Estimating the term…
Methods and therapeutics are provided for treating metabolic disorders by activation of melanocortin signaling pathways. Generally, the methods and therapeutics can induce activation of melanocortin receptor signaling to increase energy expenditure and induce weight loss. In one embodiment, a method for performing a diagnostic procedure can be chosen, energy expenditure then assess in light of the diagnostic procedure and a definitive procedure(s) can be selected dependent on the outcome of the energy assessment. In another embodiment, a diagnostic procedure can be chosen to activate melanocortin receptor pathways, energy expenditure can be assessed and a definitive procedure(s) can be chosen that selectively and optimally activate melanocortin receptor pathways.
A method of activating a melanocortin-4 receptor (MC4R) pathway in an obese subject, the method comprising:
A method of activating a melanocortin-4 receptor pathway in an obese subject, the method comprising:
A method of activating a melanocortin-4 receptor pathway to induce weight loss in an obese subject, the method comprising:
A method of activating a melanocortin-4 receptor pathway to induce weight loss in an obese subject, comprising:
Dependencies are inferred from the claim text.